Vaccinia-related kinase 1 (VRK1) confers resistance to DNA-damaging agents in human breast cancer by affecting DNA damage response

Eccles, 2013, Critical research gaps and translational priorities for thes uccessful prevention and treatment of breast cancer, Breast Cancer Research, 15, R92, 10.1186/bcr3493

Narod, 2007, Triple-negative breast cancer: clinical features and patterns of recurrence, Clin Cancer Res, 13, 4429

Bissell, 2006, Gene expression signature in organized and growth-arrested mammary acini predicts good outcome in breast cancer, Cancer research, 66, 7095, 10.1158/0008-5472.CAN-06-0515

Fournier, 2008, Prognostic breast cancer signature identified from 3D culture model accurately predicts clinical outcome across independent datasets, PLoS ONE, 3, e2994, 10.1371/journal.pone.0002994

Bissell, 2007, The morphologies of breast cancer cell lines in three-dimensional assays correlate with their profiles of gene expression, Mol Oncol, 1, 84, 10.1016/j.molonc.2007.02.004

Bertucci, 2008, Sixteen-kinase gene expression identifies luminal breast cancers with poor prognosis, Cancer Res, 68, 767, 10.1158/0008-5472.CAN-07-5516

Kim, 2007, Mitotic histone H3 phosphorylation by vaccinia-related kinase 1 in mammalian cells, Mol Cell Biol, 27, 8533, 10.1128/MCB.00018-07

Kim, 2012, Macro Histone H2A1.2 (MacroH2A1) Protein Suppresses Mitotic Kinase VRK1 during Interphase, J Biol Chem, 287, 5278, 10.1074/jbc.M111.281709

Lazo, 2004, c-Jun phosphorylation by the human vaccinia-related kinase 1 (VRK1) and its cooperation with the N-terminal kinase of c-Jun (JNK), Oncogene, 23, 8950, 10.1038/sj.onc.1208015

Lazo, 2004, Human vaccinia-related kinase 1 (VRK1) activates the ATF2 transcriptional activity by novel phosphorylation on Thr-73 and Ser-62 and cooperates with JNK, J Biol Chem, 279, 27458, 10.1074/jbc.M401009200

Kim, 2008, VRK1 phosphorylates CREB and mediates CCND1 expression, J Cell Sci, 121, 3035

Lazo, 2000, The human vaccinia-related kinase 1 (VRK1) phosphorylates threonine-18 within the mdm-2 binding site of the p53 tumour suppressor protein, Oncogene, 19, 3656, 10.1038/sj.onc.1203709

Lazo, 2004, p53 Stabilization and accumulation induced by human vaccinia-related kinase 1, Mol Cell Biol, 24, 10366, 10.1128/MCB.24.23.10366-10380.2004

Lazo, 2011, Downregulation of VRK1 by p53 in Response to DNA Damage Is Mediated by the Autophagic Pathway, PLoS ONE, 6, e17320, 10.1371/journal.pone.0017320

Levine, 2010, The origins and evolution of the p53 family of genes, Cold Spring Harb Perspect Biol, 2, a001198

Lazo, 2011, Roles of VRK1 as a new player in the control of biological processes required for cell division, Cell Signal, 23, 1267, 10.1016/j.cellsig.2011.04.002

Lazo, 2008, Human VRK1 is an early response gene and its loss causes a block in cell cycle progression, PLoS ONE, 3, e1642, 10.1371/journal.pone.0001642

Kim, 2013, Mitogen-activated protein kinase phosphatase 2 regulates histone H3 phosphorylation via interaction with vaccinia-related kinase 1, Mol Biol Cell, 24, 373, 10.1091/mbc.e12-06-0456

Traktman, 2006, The vaccinia-related kinases phosphorylate the N' terminus of BAF, regulating its interaction with DNA and its retention in the nucleus, Mol Biol Cell, 17, 2451, 10.1091/mbc.e05-12-1179

Lazo, 2009, Plk3 interacts with and specifically phosphorylates VRK1 in Ser342, a downstream target in a pathway that induces Golgi fragmentation, Mol Cell Biol, 29, 1189, 10.1128/MCB.01341-08

Lazo, 2012, Vaccinia-related Kinase 1 (VRK1) is an upstream nucleosomal kinase required for the assembly of 53BP1 foci in response to ionizing radiation-induced DNA damage, J Biol Chem, 287, 23757, 10.1074/jbc.M112.353102

Halazonetis, 2004, 53BP1, an activator of ATM in response to DNA damage, DNA repair, 3, 945, 10.1016/j.dnarep.2004.03.017

Lazo, 2006, VRK1 signaling pathway in the context of the proliferation phenotype in head and neck squamous cell carcinoma, Mol Cancer Res, 4, 177, 10.1158/1541-7786.MCR-05-0212

Lazo, 2007, Alteration of the VRK1-p53 autoregulatory loop in human lung carcinomas, Lung Cancer, 58, 303, 10.1016/j.lungcan.2007.06.023

Lazo, 2013, VRK2 identifies a subgroup of primary high-grade astrocytomas with a better prognosis, BMC clinical pathology, 13, 23, 10.1186/1472-6890-13-23

Lazo, 2007, Identification of a dominant epitope in human vaccinia-related kinase 1 (VRK1) and detection of different intracellular subpopulations, Arch Biochem Biophys, 465, 219, 10.1016/j.abb.2007.06.005

Dontu, 2009, Breast cancer cell lines contain functional cancer stem cells with metastatic capacity and a distinct molecular signature, Cancer Res, 69, 1302, 10.1158/0008-5472.CAN-08-2741

Lazo, 2010, VRK2 Inhibits Mitogen-Activated Protein Kinase Signaling and Inversely Correlates with ErbB2 in Human Breast Cancer, Mol Cell Biol, 30, 4687, 10.1128/MCB.01581-09

Lazo, 2012, VRK2 anchors KSR1-MEK1 to endoplasmic reticulum forming a macromolecular complex that compartmentalizes MAPK signaling, Cell Mol Life Sci, 69, 3881, 10.1007/s00018-012-1056-8

Kuo, 2006, A collection of breast cancer cell lines for the study of functionally distinct cancer subtypes, Cancer cell, 10, 515, 10.1016/j.ccr.2006.10.008

Aceves, 2013, Iodine and doxorubicin, a good combination for mammary cancer treatment: antineoplastic adjuvancy, chemoresistance inhibition, and cardioprotection, Mol Cancer, 12, 45, 10.1186/1476-4598-12-45

Elledge, 2002, 53BP1, a mediator of the DNA damage checkpoint, Science, 298, 1435, 10.1126/science.1076182

Lazo, 2006, p53 downregulates its activating vaccinia-related kinase 1, forming a new autoregulatory loop, Mol Cell Biol, 26, 4782, 10.1128/MCB.00069-06

Lazo, 2008, The C/H3 domain of p300 is required to protect VRK1 and VRK2 from their downregulation induced by p53, PLoS ONE, 3, e2649, 10.1371/journal.pone.0002649

Mattaj, 2008, Caenorhabditis elegans BAF-1 and its kinase VRK-1 participate directly in post-mitotic nuclear envelope assembly, Embo J, 26, 132

Traktman, 2013, Molecular genetic analysis of VRK1 in mammary epithelial cells: depletion slows proliferation in vitro and tumor growth and metastasis in vivo, Oncogenesis, 2, e48, 10.1038/oncsis.2013.11

Balmain, 2013, Rewiring of human lung cell lineage and mitotic networks in lung adenocarcinomas, Nat Commun, 4, 1701, 10.1038/ncomms2660

Manning, 2009, Structure of the pseudokinase VRK3 reveals a degraded catalytic site, a highly conserved kinase fold, and a putative regulatory binding site, Structure, 17, 128, 10.1016/j.str.2008.10.018

Yoon, 2011, NMR solution structure of human vaccinia-related kinase 1 (VRK1) reveals the C-terminal tail essential for its structural stability and autocatalytic activity, J Biol Chem, 286, 22131, 10.1074/jbc.M110.200162

Knapp, 2007, A systematic interaction map of validated kinase inhibitors with Ser/Thr kinases, Proc Natl Acad Sci U S A, 104, 20523, 10.1073/pnas.0708800104

Knapp, 2007, Insights for the development of specific kinase inhibitors by targeted structural genomics, Drug Discov Today, 12, 365, 10.1016/j.drudis.2007.03.006

Lazo, 2011, Differential Inhibitor Sensitivity between Human Kinases VRK1 and VRK2, PLoS ONE, 6, e23235, 10.1371/journal.pone.0023235

Lazo, 2013, Sensitivity of the kinase activity of human vaccinia-related kinase proteins to toxic metals, J Biol Inorg Chem, 18, 473, 10.1007/s00775-013-0992-6

Lopez, 2010, AKT1/BRCA1 in the control of homologous recombination and genetic stability: the missing link between hereditary and sporadic breast cancers, Oncotarget, 1, 691, 10.18632/oncotarget.203

Rosell, 2013, The predictive value of 53BP1 and BRCA1 mRNA expression in advanced non-small-cell lung cancer patients treated with first-line platinum-based chemotherapy, Oncotarget, 4, 1572, 10.18632/oncotarget.1157

Joensuu, 2011, Breast cancer biological subtypes and protein expression predict for the preferential distant metastasis sites: a nationwide cohort study, Breast Cancer Res, 13, R87, 10.1186/bcr2944

Lazo, 2012, Human VRK2 (Vaccinia-related Kinase 2) Modulates Tumor Cell Invasion by Hyperactivation of NFAT1 and Expression of Cyclooxygenase-2, J Biol Chem, 287, 42739, 10.1074/jbc.M112.404285

Lazo, 2013, Human VRK2 modulates apoptosis by interaction with Bcl-xL and regulation of BAX gene expression, Cell Death Dis, 4, e513, 10.1038/cddis.2013.40

Lazo, 2006, The subcellular localization of vaccinia-related kinase-2 (VRK2) isoforms determines their different effect on p53 stability in tumour cell lines, Febs J, 273, 2487, 10.1111/j.1742-4658.2006.05256.x

Forbes, 2006, Mutation analysis of 24 known cancer genes in the NCI-60 cell line set, Mol Cancer Ther, 5, 2606, 10.1158/1535-7163.MCT-06-0433

Lazo, 2007, Vaccinia-related kinase 2 modulates the stress response to hypoxia mediated by TAK1, Mol Cell Biol, 27, 7273, 10.1128/MCB.00025-07

Lazo, 2008, Modulation of interleukin-1 transcriptional response by the interaction between VRK2 and the JIP1 scaffold protein, PLoS ONE, 3, e1660, 10.1371/journal.pone.0001660